NCT01872910View on ClinicalTrials.gov

A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal

PHASE2CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Acute Pain

Interventions

DRUG

Placebo

Administered orally

DRUG

LY3023703

Administered orally

DRUG

Celecoxib

Administered orally

Trial Locations (1)

78705

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Austin

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01872910 - A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal | Biotech Hunter | Biotech Hunter